RE: AZD1656 - Ready for stage III and NCT05216172 results ?30 Aug 2023 21:36
Worth throwing this in re: Covid 19 aspect.....
"Igraine has invested in Excalibur Medicines Ltd (“EML”), a subsidiary of Excalibur Healthcare Services Ltd. EML has secured exclusive rights to and owns the COVID-19 patents on a drug, AZD1656, which is being developed as a potential therapeutic for diabetics suffering from COVID-19."
Thus far VELA and CIZ have agreed 'put' options with CONDUIT re AZD 1656 but IGRAINE/EXCALIBUR have kept very quiet